Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPX
3201
DELISTED
Marine Products Corp
MPX
| $2.27M | ﹤0.01% |
196,634
-4,850
| -2% | -$58.6K |
|
|
SEMR
3202
DELISTED
Semrush
SEMR
| $2.27M | ﹤0.01% |
190,253
+42,820
| +29% | +$644K |
|
3203
Akebia Therapeutics
AKBA
$346M
| $2.26M | ﹤0.01% |
3,152,758
-55,231
| -2% | -$118K |
|
|
RENT
3204
Rent the Runway
RENT
$119M
| $2.26M | ﹤0.01% |
16,414
+686
| +4% | +$80.5K |
|
|
PSTX
3205
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.25M | ﹤0.01% |
503,032
+12,433
| +3% | +$56.1K |
|
3206
Tyra Biosciences
TYRA
$1.53B
| $2.25M | ﹤0.01% |
210,549
+4,168
| +2% | +$49.5K |
|
|
RPC
3207
Ridgepost Capital
RPC
$978M
| $2.25M | ﹤0.01% |
185,550
-7,698
| -4% | -$95.8K |
|
|
ICVX
3208
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $2.25M | ﹤0.01% |
319,122
+90,675
| +40% | +$1.43M |
|
3209
Cytosorbents Corp
CTSO
$23.7M
| $2.24M | ﹤0.01% |
702,715
+8,800
| +1% | +$31.5K |
|
|
MILE
3210
DELISTED
Metromile, Inc. Common Stock
MILE
| $2.22M | ﹤0.01% |
1,682,842
+341,873
| +25% | +$495K |
|
|
DS
3211
DELISTED
Drive Shack Inc.
DS
| $2.21M | ﹤0.01% |
1,438,210
+152,522
| +12% | +$207K |
|
|
ATHX
3212
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.21M | ﹤0.01% |
145,979
-4,965
| -3% | -$104K |
|
3213
Flexsteel Industries
FLXS
$315M
| $2.21M | ﹤0.01% |
114,291
-31,546
| -22% | -$721K |
|
3214
Expensify
EXFY
$195M
| $2.2M | ﹤0.01% |
125,485
-8,310
| -6% | -$203K |
|
3215
Tarsus Pharmaceuticals
TARS
$2.67B
| $2.2M | ﹤0.01% |
130,758
+4,943
| +4% | +$91.7K |
|
|
LHAA
3216
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
| $2.19M | ﹤0.01% |
225,089
-14,542
| -6% | -$142K |
|
|
RMO
3217
DELISTED
Romeo Power, Inc.
RMO
| $2.19M | ﹤0.01% |
1,472,617
-616,390
| -30% | -$1.3M |
|
3218
Silicon Motion
SIMO
$8.36B
| $2.19M | ﹤0.01% |
32,728
+192
| +0.6% | +$15K |
|
3219
BayCom
BCML
$335M
| $2.18M | ﹤0.01% |
100,366
-1,986
| -2% | -$42.5K |
|
3220
Escalade
ESCA
$307M
| $2.17M | ﹤0.01% |
164,291
+5,564
| +4% | +$78.4K |
|
|
ML
3221
DELISTED
MoneyLion Inc.
ML
| $2.17M | ﹤0.01% |
28,778
| – | – |
|
|
FORA
3222
DELISTED
Forian
FORA
| $2.16M | ﹤0.01% |
310,937
+8,637
| +3% | +$63.7K |
|
3223
First Northwest Bancorp
FNWB
$106M
| $2.15M | ﹤0.01% |
97,569
| – | – |
|
|
BFX
3224
DELISTED
BowFlex Inc.
BFX
| $2.15M | ﹤0.01% |
523,137
-81,466
| -13% | -$405K |
|
3225
Canadian Solar
CSIQ
$1.05B
| $2.14M | ﹤0.01% |
60,577
+3,322
| +6% | +$100K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,081 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.